Pop Quiz
Next-Generation Alzheimer Therapies: What Every Clinician Should Know
With the approval of the first anti-amyloid antibodies, lecanemab and donanemab, the therapeutic landscape for Alzheimer disease has entered a new era—one that presents both promise and complexity. This quiz will test your understanding of current and emerging concepts in the treatment of Alzheimer disease.